ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,154Medicare Part D Prescriptions Filled, Including Refills

Rank: 572 out of 3647

$573K Total Retail Price of All Prescriptions

Rank: 862 out of 3647

538 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 10,928 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 888 770 1 2
SIMVASTATIN 589 514 2 1
METFORMIN HCL 456 401 3 6
ENALAPRIL MALEATE 407 313 4 35
OMEPRAZOLE 388 333 5 3
LISINOPRIL 376 354 6 4
CARVEDILOL 287 208 7 20
LOSARTAN POTASSIUM 261 240 8 11
HYDROCHLOROTHIAZIDE 250 246 9 9
FUROSEMIDE 249 226 10 8
METOPROLOL TARTRATE 236 188 11 7
HYDROCODONE-ACETAMINOPHEN 218 157 S3 12 12
ALENDRONATE SODIUM 204 194 13 23
INSULIN SYRINGE 187 175 14 76
VIAGRA 173 121 15 69
ATENOLOL 171 167 16 10
GLYBURIDE-METFORMIN HCL 159 144 R 17 94
LANTUS 156 145 18 59
METOPROLOL SUCCINATE 154 137 19 18
CLONIDINE HCL 152 117 20 46
WARFARIN SODIUM 144 119 21 15
ATORVASTATIN CALCIUM 141 129 22 13
TAMSULOSIN HCL 133 111 23 28
GLIPIZIDE 133 125 23 41
PANTOPRAZOLE SODIUM 129 109 25 38
GABAPENTIN 124 97 26 17
TRAMADOL HCL 111 80 27 22
LOSARTAN-HYDROCHLOROTHIAZIDE 109 80 28 48
NIFEDIPINE ER 105 93 29 67
LEVOTHYROXINE SODIUM 105 96 29 5
BUMETANIDE 101 90 31 134
GLIPIZIDE ER 99 98 32 112
LOVASTATIN 96 90 33 21
CRESTOR 94 78 34 19
MELOXICAM 93 53 35 33
FAMOTIDINE 93 79 35 61
DIOVAN 91 85 37 40
JANUVIA 90 63 38 72
TRIAMTERENE-HCTZ 85 71 39 58
HYDRALAZINE HCL 80 56 40 81
AMLODIPINE BESYLATE-BENAZEPRIL 78 73 41 74
KLOR-CON 10 77 59 42 106
IBUPROFEN 74 36 43 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 71 44 36
DONEPEZIL HCL 71 71 44 30
CIPROFLOXACIN HCL 70 61 46 53
SPIRONOLACTONE 67 47 47 77
TEMAZEPAM 66 54 48 47
ALLOPURINOL 65 45 49 37
ALPRAZOLAM 65 47 49 31
CAPTOPRIL 63 52 51 193
PLAVIX 63 63 51 39
GLIMEPIRIDE 62 49 53 45
GLYBURIDE 60 57 R 54 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 38 54 110
AZITHROMYCIN 59 49 56 34
NOVOLIN 70-30 56 55 57 130
DIGOXIN 55 55 58 51
ISOSORBIDE MONONITRATE ER 55 55 58 56
POTASSIUM CHLORIDE 54 54 60 24
DIOVAN HCT 53 33 61 80
RANITIDINE HCL 53 46 61 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.